Demographic data
| Demographics | Tested (n=557) | Combined BRCA1/2 (n=103) |
| Histology | ||
| Adenocarcinoma, NOS | 13 | 5 (38) |
| Carcinosarcoma | 6 | 1 (17) |
| Clear cell | 18 | 2 (11) |
| Endometrioid | 29 | 5* (17) |
| Low-grade serous | 10 | 0 |
| High-grade serous | 475 | 90 (19) |
| Mucinous | 4 | 0 |
| Undifferentiated | 2 | 0 |
| FHx of BC/OC | 268 | 68 (25) |
| PMHx of BC | 84 | 28 (33) |
Data are reported as number (percentage; the denominator is column 2 ‘Tested’).
*All BRCA1/2 heterozygotes had poorly differentiated (high-grade) endometrioid ovarian cancer.
BC, breast cancer; FHx, family history; NOS, not otherwise specified; OC, ovarian cancer; PMHx, medical history.